Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Revenues, net:    
Product $ 10,123,407 $ 8,537,170
Recurring 3,766,439 4,221,206
Total Net Revenue 13,889,846 12,758,376
Product 6,034,294 4,726,241
Recurring 1,069,558 1,178,077
Total Cost of Sales 7,103,852 5,904,318
Gross Profit 6,785,994 6,854,058
Operating Expenses:    
Research and development 1,174,048 984,853
Selling, general and administrative 6,248,082 5,238,700
Impairment of goodwill 2,774,016 0
Depreciation and amortization 258,517 260,830
Total Operating Expense 10,454,663 6,484,383
Income (Loss) from Operations (3,668,669) 369,675
Interest income (expense), net (18,141) (26,274)
Gain on sale of product line 41,902 15,408
Total Other Income (Expense) 23,761 (10,866)
(Loss) Income Before Provision for Income Taxes (3,644,908) 358,809
Provision (Benefit) for Income Taxes 349,823 (31,271)
Net (Loss) Income (3,994,731) 390,080
Accretion of preferred dividends and discount (905,977) (897,638)
Net income (loss) attributable to common stockholders $ (4,900,708) $ (507,558)
Net income (loss) per common share:    
Net loss attributable to common stockholders per common share - basic $ (0.04) $ 0.00
Net loss attributable to common stockholders per common share - diluted $ (0.04) $ 0.00
Weighted Average Common Shares Outstanding - basic 114,670,433 105,788,739
Weighted Average Common Shares Outstanding - diluted 114,670,433 107,387,408